Overview. Sabine AGÉ Avocat. Munich 24 February 2017
|
|
- Lorin Flowers
- 6 years ago
- Views:
Transcription
1 Literal infringement and the doctrine of equivalence from a European perspective - s that are infringed? Union IP Round Table Sabine AGÉ Avocat Paris Lyon Overview Claim construction and doctrine of equivalence under French law when compared to German or UK approaches Examples: 1.Cooking vessel 2.Helicopter landing gear 3.Clone DNA sequences 2 perspective - s that are infringed? 1
2 Claim construction Art. L of the French intellectual property code (idem Art. 69 EPC) : The extent of the protection conferred by a patent shall be determined by the terms of the claims. Nevertheless, the description and drawings shall be used to interpret the claims. construction of the terms employed and understanding of the substance of the invention through the problem solved and the essential means of the solution 3 General definition of infringement the infringing means are those which reproduce the essential means of the patented invention, i.e. the new and inventive means which are necessary and sufficient to perform the function of the invention the essential means are defined when assessing the novelty and inventive step of the claimed invention with respect to the prior art, in the framework of the nullity counterclaim which is filed in almost all cases for infringement statements of the patentee during examination and opposition are taken into account 4 perspective - s that are infringed? 2
3 From literal infringement to equivalence: a multi step test (1/4) 1 st step: does the accused means reproduces the claimed means in its (or their) form and in their function for the same result? Yes: literal infringement No: go to 2 nd step 5 From literal infringement to equivalence: a multi step test (2/4) 2 nd step: does the difference between the accused means and the claims means relate to essential features? No: literal infringement (by reproduction of the essential features) Yes: go to 3 rd step 6 perspective - s that are infringed? 3
4 From literal infringement to equivalence: a multi step test (3/4) 3 rd step: Do the claimed means implement a novel function? No: the scope of the claim is limited to the particular means and does not extend to equivalent ones Yes: go to 4 th step 7 From literal infringement to equivalence: a multi step test (4/4) 4 th step: Do the accused means perform the same function for the same result (in the same way) as the claimed means? No: no infringement Yes: infringement under the doctrine of equivalence 8 perspective - s that are infringed? 4
5 Differences with the tests applied in other European countries Obviousness of the variant is not considered as relevant: even if it is patentable, an equivalent means can be considered as infringing Intent of the one skilled in the art is irrelevant but the teaching of the patent is taken into consideration Prosecution history file is taken into account 9 Food processor with a mixing vessel and a drive mechanism for an agitator in the mixing vessel EP , claim 1: Kitchen machine (1) with a stirrer vessel (6) and a drive (8) for an agitator (10) in the stirrer vessel (6), wherein the stirrer vessel (6) in its lower region can be heated up, wherein the stirrer vessel (6) is covered by an inserted lid (14), characterised in that on the inserted lid (14) is arranged a top piece (22) which has a perforated bottom (29) for preparation by steaming of foods (38), wherein the perforations (31) are formed in a cooking material support of the bottom (29) of the top piece and condensate or moisture formed is conducted back into the stirrer vessel (6). 10 perspective - s that are infringed? 5
6 Food processor: amendment during PCT phase DE , claim 1 (priority): Kitchen machine (1) with a stirrer vessel (6) and a drive (8) for an agitator (10) in the stirrer vessel (6), wherein the stirrer vessel (6) in its lower region can be heated up, wherein the stirrer vessel (6) is covered by an inserted lid (14), characterised in that on the inserted lid (14) is arranged a top piece (22) for the stirrer vessel (6) which has a perforated bottom (29) for preparation by steaming of foods (38), wherein the perforations (31) are formed in a cooking material support of the bottom (29) of the top piece and condensate or moisture formed is conducted back into the stirrer vessel (6). Inserted lid added with regard to this prior art: 11 Food processor: the first accused device 1st accused device has a top piece made in two parts: the so-called top piece, made of metal; and a skirt-shaped annular inferior part, made of synthetics, which assembles the top piece on the vessel through a fitting method; these two parts being assembled by four rivets 12 perspective - s that are infringed? 6
7 Food processor: the second accused device 2 nd accused device has a top piece made of metal which comprises an annular lower part forming a shoulder, around which a seal: 13 Food processor: decisions on infringement (France) 1st device accused device held infringing (TGI Paris, 14/01/2011): although the accused food processors do not include an inserted lid as taught in claim 1 of patent EP , the annular lower part of the top piece is a means of a different form fulfilling the same function, namely ensuring the arrangement of the top piece above the stirrer vessel, to achieve the same result [ ]. 2 nd device held infringing under doctrine of equivalence (TGI Paris, 2/07/2015): It follows that, even if the [accused] food processor does not comprise an inserted lid as taught in claim 1 of patent EP , the embossed annular lower part of the steaming bowl combined with the peripheral seal, is a means [of a different form] fulfilling the same function, namely ensuring the arrangement of the top piece above the stirrer vessel, to achieve the same result, that is, the rise of steam from the stirrer vessel to the upper part of the top piece through the perforations provided for this purpose and the conducting back of the condensate or moisture into the stirrer vessel through the same perforations. The infringement by equivalence of claim 1 is therefore established. 14 perspective - s that are infringed? 7
8 Food processor: decisions on infringement (ES, IT, DE) Court of appeal of Barcelona held that even the 1st device does not reproduce claim 1 (CA Barcelona, 01/07/2010): The [SPTO] report affirms that inside the vessel 1 is arranged below the inserted lid 7 a top piece 2 with perforations for steaming foods. In respect of the amendment to [the] claims, it adds: On the other hand, independent claim 1 of the present applications defines a top piece 22 placed onto the inserted lid 14 with perforations for steaming foods. This useful position of a cooking insert for steaming foods onto the lid of a heatable vessel was not obvious for an expert in the field. Therefore, the subject matter of independent claim 1 meets the requirements of Article 33.2 & 3 of the Patent Cooperation Treaty in respect of novelty and inventive step. (The underlined words are from the report itself). ( ) it must be concluded that the appellant voluntarily introduced, as a distinguishing element of the claim, the assertion that the top piece for steaming foods is placed on the inserted lid of the mixing vessel (prosecution history estoppel). Same outcome in Italy with similar accused device 15 Helicopter landing gear with skids FR , claims 1 and 15: 1. Helicopter landing gear, comprising two skids (P) each having a longitudinal support stretch (1) for standing on the ground and which are connected to a 5 front cross-piece and a rear cross-piece (2) which are themselves attached to the structure of the aircraft by connecting devices (4, 6), the rear cross-piece (2) being fixed by the ends of its descending branches (2a) to the rear part of the said longitudinal support stretches (1), characterized in that each of the said skids (P) has at the front an inclined transition zone (T) with double curvature (C1, C2) orienting itself transversely with respect to the said longitudinal support stretches which stand on the ground, above the plane of the latter, the two transition zones together constituting in this way an integrated front cross-piece offset with respect to the front delimitation of the plane of contact of the said longitudinal support stretches of the skids on the ground. «15. Landing gear according to any one of the preceding claims, characterized in that the said integrated front cross-piece (8) is offset forwards with respect to the front delimitation of the plane of contact of the longitudinal support stretches of the skids on the ground. 16 perspective - s that are infringed? 8
9 Landing gear: the first accused device ( Legacy gear ) CA Paris, 20/03/2015: It constitutes the slavish copy of the illustrated landing gear as mentioned above on figure 10 of [the] patent. 17 Landing gear: the second accused device ( Production gear ) CA Paris, 20/03/2015: This second version, despite the presence of a connecting device placed on the first transition zone, and the addition of a spatula at the front end of the skid, fulfils the same functions to achieve the same result as the invention; it is without incidence that this result is not of the same degree of improvement than that of the invention. This new coupling piece still located on the first transition zone itself constitutes the first inclination, which constitutes an infringement by equivalence as this different form has the same advantages to achieve the same result since there is always at the front of the skids an inclined transition zone with a double change of direction placing the front crosspiece, an integrated front cross-piece within the meaning of the patent ( ). 18 perspective - s that are infringed? 9
10 Landing gear: Canadian decision on infringement Federal court of Canada, 30/01/2012 (confirmed in appeal, 24/09/2013): Once the claims of the patent have been construed, the Court s next task is to determine whether there has, in fact, been infringement of the patent. Very simply, there is infringement if all of the essential elements of a claim are present in the product, but there is no infringement if an essential element is different or omitted; there may still be infringement, however, if non-essential elements are substituted or omitted (Free World Trust, above, at paras 31 and 68). That said, a patent is not infringed merely because a defendant s product achieves the same result as the patented invention. The substitutability of non-essential elements derives from an informed interpretation of the language of the claims at the time of publication of the patent. Both the element specified in the claim and the variant not making use of this element must be presented to the POSITA 1. The patentee bears the burden to establish known and obvious substitutability (Free World Trust, above, at para 55). If the patentee fails to discharge that onus, the descriptive word or expression in the claim is to be considered essential unless the context of the claims language otherwise dictates (Free World Trust, above, at para 57). 1 POSITA stands for Person of Ordinary Skill in the Art 19 Landing gear: Canadian decision on infringement Federal court of Canada, 30/01/2012 (confirmed in appeal, 24/09/2013): Looking at the actual Production gear, the evidence is clear that the front cross piece of the Production gear is attached to the skids by means of saddle joints. Having heard the experts arguments and examined the Production gear at the M. facility, the Court finds that notably the Production gear does not feature the double curvature, which, as aforesaid, is one of the essential elements of claim 1. Further, the Production gear does not have the integrated front cross piece required by claim 1. The Production gear consists of a straight front cross piece connected to a straight skid via a saddle connection, with the skid continuing forward of the saddle and terminating in a ski tip. Thus, a POSITA 1 would understand that the 787 Patent contrasts two different means of attachment, and thus that a cross piece attached with a saddle is, by definition, not integrated. 20 perspective - s that are infringed? 10
11 Landing gear: US Summary judgement on a declaration for non infringement United States District Court For The District Of Columbia, 28/08/2014: The doctrine of equivalents applies when the accused device performs substantially the same function in substantially the same way to obtain the same result. Graver Tank & Mfg. Co. v. Linde Air Prods. Co., 339 U.S. 605, 608 (1950) (internal quotation marks and citation omitted). In other words, [f]or a claim limitation to be equivalently present in an accused device, there must be only insubstantial differences between the missing claim limitation and corresponding aspects of the accused device. Zodiac Pool Care, Inc. v. Hoffinger Indus., Inc., 206 F.3d 1408, 1415 (Fed. Cir. 2000) (citation omitted). Moreover, what constitutes equivalency must be determined against the context of the patent, the prior art, and the particular circumstances of the case[,] with consideration for the purpose for which an ingredient is used in a patent, the qualities it has when combined with the other ingredients, and the function which it is intended to perform. Graver Tank & Mfg. Co., 339 U.S. at Landing gear: US Summary judgement on a declaration for non infringement United States District Court For The District Of Columbia, 28/08/2014: As noted, the Court has construed the term a front to mean the portion of the skid forward of the longitudinal support stretch, i.e., the portion of the skid that contacts the ground. ( ). A front is a specific structural element and constitutes a part of the skid forward of the longitudinal support stretch. See 621 Patent, col. 5, lines ( At the front, each of the skids P has, after the corresponding longitudinal support stretch 1, a transition zone T with double curvature before constituting the integrated front cross-piece 8. ) (emphasis added). The Court agrees with B. that the part of the skid forward of the longitudinal support stretch in the Modified Gear is a ski tip. The ski tip concededly does not comprise an inclined transition zone with double curvature, as claim 1 of the patent requires. Accordingly, the Modified Gear does not contain an equivalent structure to a front of claim 1 as that term is defined by the Court. 22 perspective - s that are infringed? 11
12 Cloned DNA sequences, hybridizable with genomic RNA of lymphadenopathy-associated virus (LAV) 1 EP B1, claims 8 and 11: 8. A method for the in vitro detection of viral infection due to the LAV virus which comprises contacting a biological sample originating from a person to be diagnosed for LAV infection and containing RNA in a form suitable for hybridization with the probe of claim 7 2 under hybridizing conditions and detecting the hybridized probe. 11. The purified RNA of LAV virus which has a size from 9.1 to 9.2 kb and which corresponds to the cdna contained in lambda-j19 (CNCM I-338). 1 LAV is synonymous of HIV (Human Immunodeficiency Virus) 2 Claim 7: A probe in the in vitro detection of LAV which consists of a DNA according to any of claims 1 to 6. Claim 1: A cloned DNA which contains a DNA corresponding to the LAV retroviral genome contained in lambda-j19 (CNCM I-338), said cloned DNA including LTR elements U3, R and U5 of said retroviral genome. 23 Cloned DNA sequences: amendments to claim 8 during examination and opposition Claims 8 amended during examination and opposition: Original claim: A method for the in vitro detection of viral infection due to the LAV viruses which comprises contacting a biological sample originating from a person to be diagnosed for LAV infection and containing DNA in a form suitable for hybridization with the probe of claim 18 under hybridizing conditions and detecting the hybridized probe. Amendment during examination: A method for the in vitro detection of viral infection due to the LAV viruses which comprises contacting a biological sample originating from a person to be diagnosed for LAV infection and containing RNA in a form suitable for hybridization with the probe of claim 20 under hybridizing conditions and detecting the hybridized probe. 24 perspective - s that are infringed? 12
13 Cloned DNA sequences: accused detection kit screening test consists in three successive steps: preparing samples notably by capturing target RNA with oligonucleotides which hybridize with target RNA amplifying samples detecting each of those steps uses oligonucleotides which are not DNA probes but chimerical oligonucleotides composed of DNA and RNA (this type of molecule can be produced only by chemical synthesis and not by cloning) 25 Clone DNA sequences: claim for infringement by equivalence dismissed CA Paris, 4/03/2009: INSTITUT PASTEUR cannot use the doctrine of equivalents, since claim 8 does not cover the general means of hybridization but the specific means of hybridization of viral RNA with a probe composed of a DNA fragment which corresponds to the genome contained in the clone λ-j19; 26 perspective - s that are infringed? 13
14 Clone DNA sequences: claim for literal infringement dismissed CA Paris, 4/03/2009: ( ) scope of claim 8 is limited to a detection method involving the use of the probe, the subject-matter of claim 7, which depends on claims 1 to 6 protecting cloned DNA fragments defined by their restriction sites and corresponding to the retroviral genome contained in λ-j19. ( ) These oligonucleotides are not DNA probes but chimerical oligonucleotides composed of DNA for one part and of RNA for the second part, the part hybridizing with the HIV RNA being composed of RNA; which can be produced only by chemical synthesis and not by cloning; Nor do the promoter primers constitute probes of claim 8 since they include a promoter T7 area necessary to the function of RNA polymerase which is not found in the retroviral genome contained in λ-j19; 27 Sabine Agé Thank you 1, rue Volney Paris Tel. +33 (0) Fax +33 (0) , rue Président Édouard Herriot Lyon Tel. +33 (0) Fax +33 (0) sabine.age@veron.com perspective - s that are infringed? 14
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA ILLUMINA, INC., Plaintiff, v. NATERA, INC., Defendant. Case No. -cv-0-si ORDER DENYING MOTION TO DISMISS Re: Dkt. No. 0 Before the Court is
More informationTrilateral Project 24.1 Biotechnology Comparative Study on Biotehnology Patent Practices Comparative Study Report Contents
Trilateral Project 24.1 Biotechnology Comparative Study on Biotehnology Patent Practices Comparative Study Report Contents FOWARD 1. Requirements for Disclosure and Claims General 1.1 Claims 1.1.1 Clarity
More informationItaly Italie Italien. Report Q 150
Italy Italie Italien Report Q 150 in the name of the Italian Group by R. SGARBI, O. CAPASSO, A. COPPO, F. MACCHETTA, G. MATTEUCCI, G. ORLANDO, R. PISTOLESI Patentability Requirements and Scope of Protection
More informationWilliam E. Thomson, Clive Miles McClintock, Wei-Ning Yang, Hogan & Hartson L.L.P., Los Angeles, CA, for Plaintiff.
United States District Court, N.D. California. EXONHIT THERAPEUTICS S.A., a French societe anonyme, and Exonhit Therapeutics, Inc., a Delaware corporation, Plaintiff. v. JIVAN BIOLOGICS, INC., a Delaware
More informationAntibody Decisions and the Written Description Requirement. Workgroup
Antibody Decisions and the Written Description Requirement Workgroup 1640 2016 Overview 1. The Written Description Requirement 2. Centocor Ortho Biotech, Inc. v. Abbott Labs., 636 F.3d 1341 (Fed. Cir.
More informationProsecution History Estoppel from Dependent Claims
Prosecution History Estoppel from Dependent Claims UCB, Inc. v. Yeda Research & Dev. Co. (Fed. Cir. Sept. 8, 2016) Gary Juskowiak December 14, 2016 2016 Birch, Stewart, Kolasch & Birch, LLP Monoclonal
More informationPlaintiff s Markman Presentation
LUX, Inc. v. BrightBlue Corp. Case No. 07-cv-520 Plaintiff s Markman Presentation U.S. Patent No. 5,075,742 The 742 Patent 2 1 Overview Short Technology Tutorial Semiconductor structure for an LED The
More informationPosition Paper. Gene Patenting
The Subcommittee for Biotechnology and Plant Variety Rights Position Paper Gene Patenting About AIPPI The International Association for the Protection of Intellectual Property, generally known under the
More informationAmerican Intellectual Property Law Association Biotechnology Committee. Biotechnology in the Courts Subcommittee Report
American Intellectual Property Law Association Biotechnology Committee Biotechnology in the Courts Subcommittee Report Summaries of Recent Decisions of Interest to the Biotechnology Community Prepared
More informationUnited States Court of Appeals for the Federal Circuit BOTTOM LINE MANAGEMENT, INC., Plaintiff-Appellant, v.
United States Court of Appeals for the Federal Circuit 99-1467 BOTTOM LINE MANAGEMENT, INC., Plaintiff-Appellant, v. PAN MAN, INC. and GARRY T. LESS, Defendants-Appellees. James R. Higgins, Jr., Middleton
More informationAmendments to the German Patent and Utility Model Law
Amendments to the German Patent and Utility Model Law I. German Patent Law In order to implement the EU directive on the legal protection of biotechnological inventions ( biopatent directive, 98/44/EG
More informationPatenting biotechnological inventions
Patenting biotechnological inventions Izabela Milczarek, PhD, Specialist in Patents Department at Patpol Patpol - European and Polish Patent and Trade Mark Attorneys What is biotechnology? The 20 th century
More informationNOT FOR CITATION IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION
**E-filed 0/0/0** 0 NOT FOR CITATION IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 0 TRENT WEST, v. Plaintiff, JEWELRY INNOVATIONS, INC., TOSYALI INTERNATIONAL,
More informationNatural Products and Unnatural Law
Natural Products and Unnatural Law Warren D Woessner, J.D., Ph.D. Schwegman Lundberg & Woessner, P.A. Minneapolis, MN wwoessner@slwip.com www.patents4life.com The following remarks are provided for educational
More informationCanadian diagnostic claims where do we stand?
Canadian diagnostic claims where do we stand? November 13, 2017 Revised Chapter 17 of the Manuel of Patent Office Practice (MOPOP) released on November 10, 2017 includes a number of new sections including
More informationUnited States Court of Appeals for the Federal Circuit
Page 1 of 19 United States Court of Appeals for the Federal Circuit 01-1058, -1059 BIOGEN, INC., Plaintiff-Cross Appellant, v. BERLEX LABORATORIES, INC., Defendant-Appellant, and SCHERING AG, Defendant.
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit BIOGEN, INC., v. Plaintiff-Cross Appellant, BERLEX LABORATORIES, INC., and Defendant-Appellant, SCHERING AG, Defendant. William F. Lee, Hale and Door
More informationBasic lab techniques
Basic lab techniques Sandrine Dudoit Bioconductor short course Summer 2002 Copyright 2002, all rights reserved Lab techniques Basic lab techniques for nucleic acids Hybridization. Cut: restriction enzymes.
More informationTrilateral Project B3b Mutual understanding in search and examination. Report on Comparative study on biotechnology patent practices
Trilateral Project B3b Mutual understanding in search and examination Report on Comparative study on biotechnology patent practices Theme: Comparative study on reach-through claims San Francisco, California
More information"The European Patent Office will now grant generic claims for transgenic plants: G1/98, Plants/Novartis"
"The European Patent Office will now grant generic claims for transgenic plants: G1/98, Plants/Novartis" Dr. Hans-Rainer Jaenichen, Dr. Friederike Stolzenburg The European Patent Office will now grant
More informationBiomedical Diagnostic Patents Post Prometheus
Biomedical Diagnostic Patents Post Prometheus JPO / U.S. Bar Liaison Council Meeting June 27, 2012, Washington, D.C. Presented by Joerg-Uwe Szipl Griffin and Szipl, PC Delegate of the Virginia Bar Association
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 19 July 2005 (20.07) (OR. fr) 11341/05 PI 18
COUNCIL OF THE EUROPEAN UNION Brussels, 19 July 2005 (20.07) (OR. fr) 11341/05 PI 18 COVER NOTE from: Secretary-General of the European Commission, signed by Ms Patricia BUGNOT, Director date of receipt:
More informationFuzzy boundaries and infringement: Generics (Mylan) v Yeda & Teva
Fuzzy boundaries and infringement: Generics (Mylan) v Yeda & Teva RSC Law Group Seminar 28 November 2013 Generics (UK) Limited t/a Mylan v Yeda and Teva Relevance of the case Claims with a fuzzy boundary
More informationTRENDS AND PRACTICE TIPS IN THERAPEUTIC ANTIBODY PATENTING
TRENDS AND PRACTICE TIPS IN THERAPEUTIC ANTIBODY PATENTING 16 BY PEI WU AND JOHN P. IWANICKI Antibody technologies have evolved sideby-side with the advancement of molecular cloning, DNA sequencing, phage
More informationInvited Researcher : VivianeYumy Mitsuuchi Kunisawa (**) Introduction
13 The Patentability and Scope of Protection of Pharmaceutical Inventions Claiming Second Medical Use the Japanese and European Approaches as Possible Paradigms for a Developing Country like Brazil (*)
More informationThe Biotechnology Toolbox
Chapter 15 The Biotechnology Toolbox Cutting and Pasting DNA Cutting DNA Restriction endonuclease or restriction enzymes Cellular protection mechanism for infected foreign DNA Recognition and cutting specific
More informationReading Lecture 8: Lecture 9: Lecture 8. DNA Libraries. Definition Types Construction
Lecture 8 Reading Lecture 8: 96-110 Lecture 9: 111-120 DNA Libraries Definition Types Construction 142 DNA Libraries A DNA library is a collection of clones of genomic fragments or cdnas from a certain
More informationPersonalized Medicine and Companion Diagnostics. Joan Ellis, Ph.D. Dickinson Wright PLLC
Personalized Medicine and Companion Diagnostics Joan Ellis, Ph.D. Dickinson Wright PLLC jellis@dickinsonwright.com Personalised Medicine and Companion Diagnostics September 2015 Sarah Roques sroques@jakemp.com
More informationHot Topics in Bio Practice Hot Topics in Chemical Practice. Gerald M. Murphy, Jr. 9 th Annual PLI Patent Law Institute
Hot Topics in Bio Practice Hot Topics in Chemical Practice Gerald M. Murphy, Jr. 9 th Annual PLI Patent Law Institute HOT TOPICS IN BIO PRACTICE STATUTORY SUBJECT MATTER PTO Interim Guidance and In re
More informationMolecular Cell Biology - Problem Drill 11: Recombinant DNA
Molecular Cell Biology - Problem Drill 11: Recombinant DNA Question No. 1 of 10 1. Which of the following statements about the sources of DNA used for molecular cloning is correct? Question #1 (A) cdna
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 03-1634, -1635 TAP PHARMACEUTICAL PRODUCTS, INC. (formerly known as Tap Holdings, Inc.), and TAKEDA CHEMICAL INDUSTRIES, LTD. (now known as Takeda
More informationBiotech Patents in Europe
Biotech Patents in Europe Introduction This circular relates to biotech patent practice in Europe. It is based on our experience of drafting and prosecuting biotech applications. The circular is written
More informationIPs on sequences. Sunil Archak
IPs on sequences Sunil Archak Need to ensure conducting research without infringing upon others IP rights Need to defend own IP rights against other users Justify the substantial costs involved in research
More informationFederal Circuit addresses patent eligibility of companion diagnostic claims
Life Sciences News in Northern California - November 2009 http://www.baybio.org/wt/open/bionotes Federal Circuit addresses patent eligibility of companion diagnostic claims By: Antoinette F. Konski, Jacqueline
More information"Los Lunes del Centro de Patentes" University of Barcelona - 10 May Brian Cronin, European Patent Attorney, Nyon, Switzerland
"Los Lunes del Centro de Patentes" University of Barcelona - 10 May 2004 Brian Cronin, European Patent Attorney, Nyon, Switzerland Advanced Claim Drafting with emphasis on the allowability of, and the
More informationASIAN PATENT ATTORNEYS ASSOCIATION Recognized Group of Korea. Report to Emerging IP Rights Committee 2012, Chiang Mai
ASIAN PATENT ATTORNEYS ASSOCIATION Recognized Group of Korea Report to Emerging IP Rights Committee 2012, Chiang Mai SPECIAL TOPIC REPORT ON Business Methods and the Laws of Nature, As Discussed by the
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 02-1207, -1260 INVITROGEN CORPORATION, v. Plaintiff-Appellant, BIOCREST MANUFACTURING, L.P., STRATAGENE HOLDING CORPORTION and STRATAGENE, INC., Defendants-Cross
More informationCase 1:10-cr CKK Document 83 Filed 09/17/12 Page 1 of 11 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
Case 1:10-cr-00225-CKK Document 83 Filed 09/17/12 Page 1 of 11 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA UNITED STATES OF AMERICA, ) ) ) Case No. CR-10-225 (CKK) v. ) ) STEPHEN JIN-WOO
More informationThe Changing IP Landscape for Precision Medicine
The Changing IP Landscape for Precision Medicine Precision Medicine: Legal and Ethical Challenges Hong Kong 7-8 April, 2016 Dr Kathy Liddell & John Liddicoat Centre for Law, Medicine and Life Sciences
More informationTHE CRISPR-CAS9 DISPUTE
WHO OWNS THE INTELLECTUAL PROPERTY? THE CRISPR-CAS9 DISPUTE UTRF Tech Talks Dr. Lakita Cavin February 23, 2017 WHAT IS CRISPR-Cas9 Clustered Regularly-Interspaced Short Palindromic Repeats/CRISPR associated
More informationDeciphering the Patent-Eligibility Message in Prometheus, Myriad and Classen
Deciphering the Patent-Eligibility Message in Prometheus, Myriad and Classen It has been a little more than eighteen months after the Supreme Court issued its opinion on the patent-eligibility of (business)
More informationMolecular Biology: Gene cloning
Molecular Biology: Gene cloning Author: Prof Marinda Oosthuizen Licensed under a Creative Commons Attribution license. CLONING VECTORS The central component of a gene cloning experiment is the vector or
More informationZBM Patents. Peter Markvardsen, Partner, European Patent Attorney. Centro de Patentes, Lunes 4 of October
ZBM Patents www.zbm-patents.eu Peter Markvardsen, Partner, European Patent Attorney Centro de Patentes, Lunes 4 of October 2010 Headings Classical absolute product protection - general discussion European
More informationUnited States District Court, D. Delaware. AFFYMETRIX, INC, Plaintiff. v. ILLUMINA, INC, Defendant. No. CIV.A JJF. Aug. 16, 2006.
United States District Court, D. Delaware. AFFYMETRIX, INC, Plaintiff. v. ILLUMINA, INC, Defendant. No. CIV.A. 04-901 JJF Aug. 16, 2006. Background: Holder of patents related to methods and apparatus for
More informationThe Role That Sequence Searches Play in Patent Prosecution and FTO Analyses Cambridge, MA February 12, 2007
Mario Cloutier Patent Agent The Role That Sequence Searches Play in Patent Prosecution and FTO Analyses Cambridge, MA February 12, 2007 2007 Millennium Pharmaceuticals Inc. The Role That Sequence Searches
More informationPCR and qpcr solutions
A A A C A A A C A A A C A A A C A A A T A A A C A A A C A A A C A A A C A A A T A A A C A A A C A A A C A A A C A A C G A A A A A A A A A A A A A A A A A A A A A A C A A A C A A A C A A A C A A A A A C
More informationChapter 20 Recombinant DNA Technology. Copyright 2009 Pearson Education, Inc.
Chapter 20 Recombinant DNA Technology Copyright 2009 Pearson Education, Inc. 20.1 Recombinant DNA Technology Began with Two Key Tools: Restriction Enzymes and DNA Cloning Vectors Recombinant DNA refers
More informationDate January 20, 2017 Court Intellectual Property High Court Case number 2016 (Ne) 10046
Date January 20, 2017 Court Intellectual Property High Court Case number 2016 (Ne) 10046 Special Division A case in which the court dismissed a claim for an injunction against the manufacture, sale or
More informationLecture 3 (FW) January 28, 2009 Cloning of DNA; PCR amplification Reading assignment: Cloning, ; ; 330 PCR, ; 329.
Lecture 3 (FW) January 28, 2009 Cloning of DNA; PCR amplification Reading assignment: Cloning, 240-245; 286-87; 330 PCR, 270-274; 329. Take Home Lesson(s) from Lecture 2: 1. DNA is a double helix of complementary
More informationCase 0:15-cv JIC Document 119 Entered on FLSD Docket 04/07/2016 Page 1 of 12 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA
Case 0:15-cv-61631-JIC Document 119 Entered on FLSD Docket 04/07/2016 Page 1 of 12 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CASE NO. 15-61631-CIV-COHN/SELTZER AMGEN, INC., and AMGEN MANUFACTURING
More informationCHAPTER 20 DNA TECHNOLOGY AND GENOMICS. Section A: DNA Cloning
Section A: DNA Cloning 1. DNA technology makes it possible to clone genes for basic research and commercial applications: an overview 2. Restriction enzymes are used to make recombinant DNA 3. Genes can
More informationPatenting personalised medicines in Europe. By Christian Heubeck and Wolfgang Weiss Weickmann & Weickmann
Patenting personalised medicines in Europe By Christian Heubeck and Wolfgang Weiss Weickmann & Weickmann Engineering Chemistry Life Sciences Trademarks Designs With the power of a globally acting law firm
More informationSpecific Types of Claims
Specific Types of Claims Dr. Shoichi Okuyama Okuyama & Sasajima Tokyo Japan February 2017 Kuala Lumpur Importance of having different categories Product and method What distinguishes a method from a product?
More informationPost-Grant for Practitioners
Part 1: IPR and CBM (the first 5 months) Webinar Series February 13, 2013 Karl Renner & Dorothy Whelan Co-Chairs of Post-Grant Practice Agenda I. Introduction to Webinar Series II. Statistics III. Case
More informationPaper Entered: August 1, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD
Trials@uspto.gov Paper 9 571-272-7822 Entered: August 1, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD UNIFIED PATENTS INC., Petitioner, v. ROTHSCHILD CONNECTED
More informationBIOTECHNOLOGY. Biotechnology is the process by which living organisms are used to create new products THE ORGANISMS
BIOTECHNOLOGY Biotechnology is the process by which living organisms are used to create new products THE ORGANISMS Bacteria: are prokaryotic organisms that contain circular DNA and no organelles. They
More informationTrilateral Project WM4 Comparative studies in new technologies (biotechnology, business methods, etc.)
Trilateral Project WM4 Comparative studies in new technologies (biotechnology, business methods, etc.) Report on comparative study on Examination Practice Relating to Single Nucleotide Polymorphisms (SNPs)
More informationPlease find below and/or attached an Office communication concerning this application or proceeding.
UNITED STA TES p A TENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit INTERVET INC., Plaintiff-Appellee, v. MERIAL LIMITED AND MERIAL SAS, Defendants-Appellants. 2009-1568 Appeal from the United States District Court
More informationINNOVAPI WP3 Activity 3 Health Parameters
Harmonization of methods for measuring viral load and bio-markers of aging Stage1 : Quality check of extracted RNA in Torino A qpcr on 18S gene showed that the extracted samples also contain genomic DNA.
More informationCouncil Directive 98/44/EC on Biotechnological Inventions Arts. 8, 9, Secs. 53, 53a Dutch Patent Act - "Roundup Ready"
The Netherlands Council Directive 98/44/EC on Biotechnological Inventions Arts. 8, 9, Secs. 53, 53a Dutch Patent Act - "Roundup Ready" The following questions are referred to the European Court of Justice:
More informationPharmaceutical. Written Descriptions and Biotech Patents. By David A. Gass, Esq., and Sharon M. Sintich, Ph.D.
COMMENTARY REPRINTED FROM VOLUME 24, ISSUE 7 / SEPTEMBER 2008 Written Descriptions and Biotech Patents By David A. Gass, Esq., and Sharon M. Sintich, Ph.D. Patent rights serve as a foundation and lifeblood
More informationAMP v. USPTO (Federal Circuit Court of Appeals Decision, July 2011.)
AMP v. USPTO (Federal Circuit Court of Appeals Decision, July 2011.) US Constitution, Article 1 Section 8 (Clause 8): [Congress shall have the power] To promote the Progress of Science and useful Arts,
More informationBrussels, XXX [ ](2016) XXX draft. Commission Notice
Ref. Ares(2016)6236175-03/11/2016 EUROPEAN COMMISSION Brussels, XXX [ ](2016) XXX draft Commission Notice on certain articles of Directive 98/44/EC of the European Parliament and of the Council of 6 July
More informationPersonalized medicine has been hailed as a
34 Biotechnology Law Report 39 Number 1, 2015 # Mary Ann Liebert, Inc. DOI: 10.1089/blr.2015.9998 The Best Offense Is a Good Defense: Patent Prosecution Strategies During Personalized Medicine Drug Development
More informationPatenting genes: how do India and the US
Page 1 of 5 Patenting genes: how do India and the US compare? 17-11-2016 Swarup Kumar Vitaly Galdaev / Shutterstock.com India s position on patenting genes borrows heavily from that of the US, but will
More informationFactors affecting PCR
Lec. 11 Dr. Ahmed K. Ali Factors affecting PCR The sequences of the primers are critical to the success of the experiment, as are the precise temperatures used in the heating and cooling stages of the
More informationJames J. Foster, Jason M. Honeyman, Michael A. Albert, Wolf, Greenfield & Sacks, PC, Boston, MA, for Diomed, Inc.
United States District Court, D. Massachusetts. DIOMED, INC, v. ANGIODYNAMICS, INC. No. Civ.A.04-CV-10019-RG April 12, 2005. James J. Foster, Jason M. Honeyman, Michael A. Albert, Wolf, Greenfield & Sacks,
More informationGenetics Lecture 21 Recombinant DNA
Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of
More informationPlease find below and/or attached an Office communication concerning this application or proceeding.
United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 2007-1266 CARNEGIE MELLON UNIVERSITY and THREE RIVERS BIOLOGICALS, INC., v. Plaintiffs-Appellants, HOFFMANN-LA ROCHE INC., ROCHE MOLECULAR SYSTEMS,
More informationDate July 16, 2015 Court Intellectual Property High Court Case number 2015 (Gyo-Ke) 10002
Date July 16, 2015 Court Intellectual Property High Court Case number 2015 (Gyo-Ke) 10002 Fourth Division A case in which, with respect to a trademark consisting of a combination of a figure and a color
More informationPlant Related Inventions Experiences from a seed industry perspective
Plant Related Inventions Experiences from a seed industry perspective Dr. Michael A. Kock Geneva, July 14, 2009 Demand is driven by population growth and land scarcity World population People fed per hectare
More informationIN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION CLAIM CONSTRUCTION MEMORANDUM OPINION AND ORDER
Kroy IP Holdings, LLC v. Autozone, Inc., Doc. 162 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION KROY IP HOLDINGS, L.L.C., Plaintiff, v. AUTOZONE, INC., Defendant.
More informationBIOLOGICAL AND PHARMACEUTICAL PATENTS IN MEXICO
BIOLOGICAL AND PHARMACEUTICAL PATENTS IN MEXICO Ing. Eugenio Pérez INDEX Key facts Patent division at IMPI Flow chart of Patent Process Requirements for Patent Protection Plant Varieties Protection and
More informationIntroduction to Myriad
Panelists: Alex Kozinski, Chief Judge of US Court of Appeals for the Ninth Circuit Nathan Kelley, Deputy Solicitor at US Patent and Trademark Office Ben Jackson, Senior Director of Legal Affairs at Myriad
More informationGeneral Terms and Conditions of Alfons W. Gentner Verlag GmbH und Co. KG for Advertising in Online Media
General Terms and Conditions of Alfons W. Gentner Verlag GmbH und Co. KG for Advertising in Online Media 1. Scope of Application: Advertising Order (1) The following General Terms and Conditions in their
More informationAssociation for Molecular Pathology v. Myriad Genetics, Inc. The decision and its implications
Association for Molecular Pathology v. Myriad Genetics, Inc. The decision and its implications November 1, 2013 Scott D. Miller, J.D., Ph.D. IP Counsel Leader Life Technologies Corporation DNA Can Be Better
More informationPaper No Entered: July 20, 2018 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD
Trials@uspto.gov Paper No. 9 571-272-7822 Entered: July 20, 2018 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD COMTECH MOBILE DATACOM CORPORATION, Petitioner, v. VEHICLE
More informationPATENTABILITY OF MICRO-ORGANISMS: COMPARATIVE ANALYSIS
PATENTABILITY OF MICRO-ORGANISMS: COMPARATIVE ANALYSIS Anandita Arora 1 INTRODUCTION PATENTS A patent is an intellectual property right relating to inventions and is the grant of exclusive rights, for
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit BILLUPS-ROTHENBERG, INC., Plaintiff-Appellant, v. ASSOCIATED REGIONAL AND UNIVERSITY PATHOLOGISTS, INC. (DOING BUSINESS AS ARUP LABORATORIES) AND
More informationPATENT 213 NEW THINKING ON WRITTEN DESCRIPTION, ENABLEMENT AND PATENT ELIGIBILITY ISSUES
Page 1 of 7 PATENT 213 NEW THINKING ON WRITTEN DESCRIPTION, ENABLEMENT AND PATENT ELIGIBILITY ISSUES A Rare Win for a Medical Testing Patent in Exergen Corporation V. Kaz USA, Inc. By Nicholas J. Landau,
More informationGM Crops in the Courts: Three Recent US Patent Decisions
University of Oklahoma College of Law From the SelectedWorks of Drew L. Kershen July, 2013 GM Crops in the Courts: Three Recent US Patent Decisions Drew L. Kershen, University of Oklahoma College of Law
More informationGenetic Engineering & Recombinant DNA
Genetic Engineering & Recombinant DNA Chapter 10 Copyright The McGraw-Hill Companies, Inc) Permission required for reproduction or display. Applications of Genetic Engineering Basic science vs. Applied
More informationPaper 11 Tel: Entered: September 11, 2014 UNITED STATES PATENT AND TRADEMARK OFFICE
Trials@uspto.gov Paper 11 Tel: 571-272-7822 Entered: September 11, 2014 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD SAFEWAY, INC. and THE KROGER CO., Petitioner,
More informationEP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2012/33
(19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 487 726 A1 (43) Date of publication: 15.08.2012 Bulletin 2012/33 (51) Int Cl.: H01L 31/042 (2006.01) H01L 31/048 (2006.01) (21) Application number: 11192149.0
More informationCase 1:14-cv LPS Document 581 Filed 08/28/17 Page 1 of 8 PageID #: IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:14-cv-00846-LPS Document 581 Filed 08/28/17 Page 1 of 8 PageID #: 37563 IDENIX PHARMACEUTICALS LLC UNIVERSITA DEGLI STUDI DI CAGLIARI, IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
More informationFun with DNA polymerase
Fun with DNA polymerase Why would we want to be able to make copies of DNA? Can you think of a situation where you have only a small amount and would like more? Enzymatic DNA synthesis To use DNA polymerase
More informationTD/TC/WP(98)15/FINAL Or. Eng. Working Party of the Trade Committee INTELLECTUAL PROPERTY PRACTICES IN THE FIELD OF BIOTECHNOLOGY
Unclassified TD/TC/WP(98)15/FINAL TD/TC/WP(98)15/FINAL Or. Eng. Unclassified Organisation de Coopération et de Développement Economiques OLIS : 01-Feb-1999 Organisation for Economic Co-operation and Development
More informationTable of contents. I. Description...2. II. Principle...2. III. Kit Components...3. IV. Storage...3. V. Features...4. VI. Precautions for Operation...
Table of contents I. Description...2 II. Principle...2 III. Kit Components...3 IV. Storage...3 V. Features...4 VI. Precautions for Operation...4 VII. Protocol...4 VIII.Experiment Example...6 IX. Appendix...8
More informationTEPZZ Z 94A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION
(19) TEPZZ Z 94A_T (11) EP 3 023 394 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.0.16 Bulletin 16/21 (21) Application number: 139737.0 (1) Int Cl.: C03B 27/04 (06.01) C03B 27/044 (06.01)
More informationUnit 8: Genomics Guided Reading Questions (150 pts total)
Name: AP Biology Biology, Campbell and Reece, 7th Edition Adapted from chapter reading guides originally created by Lynn Miriello Chapter 18 The Genetics of Viruses and Bacteria Unit 8: Genomics Guided
More informationNational Workshop on the Patent Cooperation Treaty (PCT) System. Unity of Invention. November 28, 2016 Japan Patent Office
National Workshop on the Patent Cooperation Treaty (PCT) System Unity of Invention November 28, 2016 Japan Patent Office 0 Outline I. Definition and Purpose of Unity II. How to examine Unity 1 I. Definition
More informationJeffrey I. Kaplan, Esq., Michael R. Gilman, Esq., Kaplan Gilman Gibson & Dernier LLP, Woodbridge, NJ, for Plaintiff Source Search Technologies, LLC.
United States District Court, D. New Jersey. SOURCE SEARCH TECHNOLOGIES, LLC, Plaintiff. v. LENDING TREE, LLC, IAC/InterActiveCorp, and Service Magic, Inc, Defendant. Civ. No. 04-4420 (DRD) Oct. 16, 2006.
More informationNext Gen Sequencing. Expansion of sequencing technology. Contents
Next Gen Sequencing Contents 1 Expansion of sequencing technology 2 The Next Generation of Sequencing: High-Throughput Technologies 3 High Throughput Sequencing Applied to Genome Sequencing (TEDed CC BY-NC-ND
More informationPaper No Entered: June 11, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD
Trials@uspto.gov Paper No. 8 571-272-7822 Entered: June 11, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD CEPHEID, Petitioner, v. ROCHE MOLECULAR SYSTEMS, INC.
More informationAustralian Myriad appeal confirms patentabililty of genes. By Vaughan Barlow 1
Australian Myriad appeal confirms patentabililty of genes By Vaughan Barlow 1 1. Introduction The recent decision in D Arcy v Myriad Genetics Inc [2014] FCAFC 65 (5 September 2014) by the Full Court of
More informationMEMORANDUM OPINION AND ORDER. Introduction. Background FN1
United States District Court, D. Minnesota. MEDTRONIC, INC, Plaintiff. v. BOSTON SCIENTIFIC CORPORATION, and SciMed Life Systems, Inc, Defendants. No. 99-1035 RHK/FLN Aug. 31, 2001. A. James Anderson and
More informationChapter 15 Gene Technologies and Human Applications
Chapter Outline Chapter 15 Gene Technologies and Human Applications Section 1: The Human Genome KEY IDEAS > Why is the Human Genome Project so important? > How do genomics and gene technologies affect
More informationComputational Biology 2. Pawan Dhar BII
Computational Biology 2 Pawan Dhar BII Lecture 1 Introduction to terms, techniques and concepts in molecular biology Molecular biology - a primer Human body has 100 trillion cells each containing 3 billion
More information